Delphi Panel on the Relationship Between Long-Acting Injectable Antipsychotics and Longer-Term Functional Recovery in First-Episode and Early-Phase Schizophrenia Patients

被引：0
|
作者：
Kane, John M. [1 ]
Yildirim, Murat [2 ]
Madera-McDonough, Jessica [3 ]
Arango, Celso [4 ]
Fagiolini, Andrea [5 ]
Gorwood, Philip [6 ]
Sahota, Navdeep [7 ]
Correll, Christoph U. [8 ]
机构：
[1] Northwell Hlth, Feinstein Inst Med Res, Inst Behav Sci, New York, NY USA
[2] H Lundbeck & Co AS, Copenhagen, Denmark
[3] Otsuka Pharmaceut Co Ltd, Tokyo, Japan
[4] Hosp Gen Univ Gregorio Maranon, Child & Adolescent Dept Psychiat, Madrid, Spain
[5] Univ Siena, Div Psychiat, Siena, Italy
[6] Univ Paris, Inst Psychiat & Neurosci Paris, Paris, France
[7] OPEN Hlth, London, England
[8] Hofstra Northwell Hempstead, Donald & Barbara Zucker Sch Med, Dept Psychiat & Mol Med, New York, NY USA
来源：
CNS SPECTRUMS | 2023年 / 28卷 / 02期
关键词：
D O I：
10.1017/S1092852923001931
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：253 / 253
页数：1
相关论文
共 50 条
  • [41] In-Hospital Use of Long-Acting Injectable Antipsychotics and Readmission Risk in Patients With First-Admission Schizophrenia in Taiwan
    Chen, Wei
    Wu, Chi-Shin
    Liu, Chen-Chung
    Kuo, Po-Hsiu
    Chan, Hung-Yu
    Lin, Yi-Hsuan
    Chung, Yu-Chu Ella
    Chen, Wei J.
    JAMA NETWORK OPEN, 2024, 7 (06) : e2417006
  • [42] Retrospective Analysis of the Effectiveness and Tolerability of Long-Acting Paliperidone Palmitate Antipsychotic in Adolescent First-Episode Schizophrenia Patients
    Petric, Daniela
    Racki, Valentino
    Gaco, Nadija
    Kastelan, Ana
    Graovac, Mirjana
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2019, 29 (03) : 197 - 204
  • [43] Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection
    Emsley, Robin
    Oosthuizen, Petrus
    Koen, Liezl
    Niehaus, Dana J. H.
    Medori, Rossella
    Rabinowitz, Jonathan
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (06) : 325 - 331
  • [44] Cognition as a Moderator of Relapse Risk Among Patients With Early Phase Schizophrenia Treated With Long-Acting Injectable Antipsychotics: Data From the Prelapse Trial
    Robinson, Delbert
    Schooler, Nina
    John, Majnu
    Marcy, Patricia
    Kane, John
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 344 - 344
  • [45] Cognition as a Moderator of Relapse Risk Among Patients With Early Phase Schizophrenia Treated With Long-Acting Injectable Antipsychotics: Data From the Prelapse Trial
    Robinson, Delbert
    Schooler, Nina
    John, Majnu
    Marcy, Patricia
    Kane, John
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 344 - 344
  • [46] Functional recovery in patients treated with long-acting risperidone as a first-line treatment for first-episode psychosis: 6-month interim analyses
    Medori, R
    Oosthuizen, P
    Koen, L
    Niehaus, D
    Emsley, R
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 58 - 58
  • [47] Remission in schizophrenia: Results from a 12-month analysis of long-acting risperidone in patients with first-episode psychosis
    Emsley, R.
    Oosthuizen, P.
    Koen, L.
    Niehaus, D.
    Lex, A.
    Medori, R.
    SCHIZOPHRENIA RESEARCH, 2006, 86 : S131 - S131
  • [48] Comparison of subjective experiences and effectiveness of first-generation long-acting injectable antipsychotics and risperidone long-acting injectables in patients with schizophrenia (vol 36, pg 492, 2016)
    Chen, W-Y
    Lin, S-K.
    Lin, S. K.
    Pan, C. H.
    Chen, C. H.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (05) : 434 - 434
  • [49] Effectiveness of oral versus long-acting antipsychotic treatment early-phase schizophrenia patients: an openlabel randomized trial
    Winter, I.
    Davidson, M.
    Fleischhacker, W.
    Kahn, R.
    EUROPEAN PSYCHIATRY, 2022, 65 : S130 - S130
  • [50] Comparison of Clinical Characteristics Between the Patients with Schizophrenia on Clozapine Treatment with Those Taking Combination of Long-Acting Injectable and Oral Antipsychotics
    Kokurcan, Ahmet
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2019, 56 (03): : 219 - 223
12345